PanthaCore Consulting connects global sponsors, MedTech manufacturers, start-up founders, and CROs to investigator sites across the UK and African countries — with the precision, compliance, and speed modern trials demand.
We specialise in country, site, and study feasibility, trial set-up and management, protocol design, regulatory support, and academic–industry collaboration — guiding every project from idea to commercialisation with precision, compliance, and care.
We work with sponsors, MedTech manufacturers, and CROs based anywhere across Europe, the Americas, Asia, or Africa — connecting them to investigator sites across those same regions. PanthaCore Consulting manages study set-up and delivery end-to-end, regardless of geography.
Based anywhere across Europe, the Americas, Asia, or Africa.
PanthaCore Consulting manages feasibility, regulatory approval, site activation, and oversight — the single accountable link between sponsor and site, wherever each is based.
Located anywhere across Europe, the Americas, Asia, or Africa.
We understand what sponsors, study sites, and CROs need. We're here to help translate science into scalable, patient-centred clinical research.
We follow ICH-GCP principles and standard operating procedures to ensure quality at every step of the trial lifecycle.
End-to-end support for ethics committee submissions and regulatory requirements, prepared with the accuracy reviewers demand.
Dedicated coordination with investigators and study staff to ensure smooth trial execution from start-up to close-out.
Transparent, timely, and proactive communication with sponsors and CROs throughout every phase of the study.
Focused on patient safety, comfort, and confidentiality throughout the study, without compromise.
We uphold the highest standards of ethics, integrity, and compliance — not as a checklist, but as a core operating principle.
From first regulatory submission to final archival, we manage every layer of site operations a sponsor needs, under one accountable team.
At PanthaCore Consulting, we believe success in clinical research is built on a clear, structured approach. That's why our process is designed to deliver precision, compliance, and measurable impact at every stage — from the first conversation to the final report.
We assess study readiness against the real requirements of country and site before any commitment is made — infrastructure, investigator capacity, and patient population evaluated honestly, so feasibility decisions are grounded in fact rather than assumption.
We act as the bridge between sponsors, CROs, and site teams, keeping investigators aligned with study expectations and site staff supported through every stage of execution.
IRAS, MHRA, REC, and FDA submission documentation prepared with the accuracy and completeness needed for smooth committee review, reducing the back-and-forth that delays study start-up.
Structured support for identifying eligible patients and keeping them engaged for the full duration of a study, recognising that retention is as critical to data quality as recruitment itself.
Visit scheduling and subject follow-up managed closely, so protocol-mandated timelines are met and no subject contact point is missed across the course of the study.
Source documentation and study files organised and maintained to inspection-ready standard throughout the study, not assembled retroactively when an audit is announced.
Case report forms designed with the precision to ensure clean data collection, reducing query rates and protecting data integrity from first entry.
Every study coordinated under ICH Good Clinical Practice standards — compliance built into daily operations, not treated as a final checklist before submission.
Clear, consistent communication maintained between sponsors, CROs, investigators, and research teams, so information moves accurately and on time across every party involved in the study.
Send us your protocol details and we'll respond within 24 hours with a preliminary feasibility assessment.
Collaborate. Innovate. Deliver. — Ready to take your research from concept to clinic?
Start the Conversation →Most trial delays don't happen because of the protocol. They happen because of how sites are set up, how documentation is managed, and how communication breaks down between sponsors, CROs, and investigators.
At PanthaCore Consulting, every engagement follows the same structured methodology, regardless of study size, therapeutic area, or sponsor. Consistency in process is how we protect timelines and data quality.
From first protocol review to final archival — the same structured process, every time.
We study your protocol in depth before committing to timelines — no surprises at initiation.
Regulatory IRAS submissions, REC, MHRA, and FDA approvals, and local NHS R&D contract submission tracked to the day.
Consultant CRA on the ground, monitors in the loop, data clean from visit one.
Inspection-ready documentation, reconciled financials, and clean site closure.
The PanthaCore Consulting team brings direct experience from academia, CRO, and NHS hospital research settings — not external consultants learning the space, but people who have worked the operational side of clinical trials before building a company to do it better.
Dr Nganwuchu has eight years of experience in clinical research, spanning preclinical work through to patient-focused clinical studies. She holds a First-Class Honours degree in Biochemistry, a Master of Science in Drug Toxicology and Safety Pharmacology, and a Doctorate in Life Sciences, with research focused on translational and clinical research. She is a Clinical Research and Operations Manager with a proven track record across NHS, academic, and CRO environments — where scientific rigour meets operational excellence and patient-centred delivery.
"I specialise in translating complex research concepts into practical, high-performing clinical studies — spanning multi-site international RCTs, portfolios exceeding £2M, and complex regulatory pathways through IRAS submissions, including MHRA and REC approvals.
As founder of PanthaCore Consulting, I provide bespoke consultancy supporting MedTech, biotech, and pharmaceutical organisations, CROs, and academic institutions — bridging the gap between innovation and real-world patient impact."
Recognising the growing need for reliable site management support in an evolving clinical research landscape, she established PanthaCore Consulting to bridge the gap between sponsors, CROs, investigators, and research sites. Her focus is on building an organisation that delivers efficient study execution, regulatory compliance, transparent communication, and patient-centred research practices.
Under her leadership, PanthaCore Consulting is committed to supporting high-quality clinical trials and advancing healthcare through ethical, innovative research operations. She is passionate about building systems, strengthening governance, and enabling research teams to succeed in highly regulated environments — ensuring the work is not only robust, but meaningful for the patients it ultimately serves.
"Chi is always a pleasure to work with — organised and knowledgeable, with an impeccable work ethic. She understands clinical trials end to end, including clinical delivery, giving her an excellent grasp of the whole process, from regulatory standards to the more pragmatic aspects of clinical trials. I would highly recommend Chi to any company requiring clinical trial support."
Get in touch to discuss your project needs.
Send us your protocol details and we'll respond within 24 hours with a preliminary feasibility assessment.
Collaborate. Innovate. Deliver.
Start the Conversation →